Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mike E. Craanen is active.

Publication


Featured researches published by Mike E. Craanen.


Gut | 2009

Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression

Beatriz Carvalho; Cindy Postma; Sandra Mongera; Erik S. Hopmans; S Diskin; M A van de Wiel; W van Criekinge; Olivier Thas; A Matthäi; Miguel A. Cuesta; J S Terhaar sive Droste; Mike E. Craanen; Evelin Schröck; Bauke Ylstra; Gerrit A. Meijer

Objective: This study aimed to identify the oncogenes at 20q involved in colorectal adenoma to carcinoma progression by measuring the effect of 20q gain on mRNA expression of genes in this amplicon. Methods: Segmentation of DNA copy number changes on 20q was performed by array CGH (comparative genomic hybridisation) in 34 non-progressed colorectal adenomas, 41 progressed adenomas (ie, adenomas that present a focus of cancer) and 33 adenocarcinomas. Moreover, a robust analysis of altered expression of genes in these segments was performed by microarray analysis in 37 adenomas and 31 adenocarcinomas. Protein expression was evaluated by immunohistochemistry on tissue microarrays. Results: The genes C20orf24, AURKA, RNPC1, TH1L, ADRM1, C20orf20 and TCFL5, mapping at 20q, were significantly overexpressed in carcinomas compared with adenomas as a consequence of copy number gain of 20q. Conclusion: This approach revealed C20orf24, AURKA, RNPC1, TH1L, ADRM1, C20orf20 and TCFL5 genes to be important in chromosomal instability-related adenoma to carcinoma progression. These genes therefore may serve as highly specific biomarkers for colorectal cancer with potential clinical applications.


Digestive Surgery | 2007

Laparoscopic versus Open Total Mesorectal Excision: A Comparative Study on Short-Term Outcomes

A.A.F.A. Veenhof; Alexander Engel; Mike E. Craanen; S. Meijer; E.S.M. de Lange-de Klerk; D. L. van der Peet; W. J. H. J. Meijerink; M. A. Cuesta

Background: Laparoscopic total mesorectal excision (TME) is being used in rectal cancer more frequently. The aim of this study was to analyze the differences in short-term outcomes between open and laparoscopic TME. Methods: In this nonrandomized consecutive study, the short-term outcomes of 100 patients undergoing TME for proven rectal cancer were analyzed. Results: Two groups of 50 patients underwent an open or laparoscopic TME for rectal cancer. Both groups were comparable. Laparoscopic surgery took longer to perform (250 vs. 197.5 min, p < 0.01), but was accompanied by less blood loss (350 vs. 800 ml, p < 0.01). Enteric function recovered sooner after laparoscopy. The numbers of major and minor complications were comparable between both groups, although fewer patients had major complications in the laparoscopic group (6 vs. 15 patients, p = 0.03). Hospital stay was shorter for patients who underwent a laparoscopic abdominoperineal resection (10 vs. 12 days, p = 0.04). Median follow-up was 17 months for the laparoscopic group and 22 months for the open group. Survival analyses between the groups showed no statistical difference in disease-free and overall survival. Conclusion: This study shows that laparoscopic TME for rectal cancer is a safe and feasible technique with some short-term benefits over open TME.


Molecular Imaging and Biology | 2003

Positron emission tomography using 2-deoxy-2-[18F]-fluoro-D-glucose for response monitoring in locally advanced gastroesophageal cancer; a comparison of different analytical methods

Judith R. Kroep; Cornelis J. van Groeningen; Miguel A. Cuesta; Mike E. Craanen; Otto S. Hoekstra; Emile F.I. Comans; Elisabeth Bloemena; Corneline J. Hoekstra; Richard P. Golding; Jos W. R. Twisk; Godefridus J. Peters; Adriaan A. Lammertsma


BMC Cancer | 2010

Does delay in diagnosing colorectal cancer in symptomatic patients affect tumor stage and survival? A population-based observational study

Jochim S. Terhaar sive Droste; Frank A. Oort; René W. van der Hulst; Veerle M.H. Coupé; Mike E. Craanen; Gerrit A. Meijer; Linde M. Morsink; Otto Visser; Roy Lj van Wanrooij; Chris Jj Mulder


International Journal of Colorectal Disease | 2007

Preoperative radiation therapy for locally advanced rectal cancer: a comparison between two different time intervals to surgery

A.A.F.A. Veenhof; R. H. J. Kropman; Alexander Engel; Mike E. Craanen; Sybren Meijer; O. W. M. Meijer; D. L. van der Peet; M. A. Cuesta


World Journal of Gastroenterology | 2009

Colonoscopic yield of colorectal neoplasia in daily clinical practice

Jochim S. Terhaar sive Droste; Mike E. Craanen; René W. van der Hulst; Joep F. W. M. Bartelsman; Dick P. Bezemer; Kim R. Cappendijk; Gerrit A. Meijer; Linde M. Morsink; Pleun Snel; Hans A. R. E. Tuynman; Roy van Wanrooy; Eric C. Wesdorp; Chris J. Mulder


World Journal of Gastroenterology | 2006

On attitudes about colorectal cancer screening among gastrointestinal specialists and general practitioners in the Netherlands

J. S. Terhaar sive Droste; Gdn Heine; Mike E. Craanen; H Boot; Cjj Mulder


Cellular Oncology | 2008

Integration of DNA and expression microarray data unravels seven putative oncogenes on 20Q amplicon involved in colorectal adenoma to carcinoma progression

Beatriz Carvalho; Cindy Postma; Sandra Mongera; Erik S. Hopmans; Sharon Diskin; Mark A. van de Wiel; Wim Van Criekinge; Olivier Thas; Anja Mathhai; Miguel A. Cuesta; Jochim Terhaar; Mike E. Craanen; Evelin Schröck; Bauke Ylstra; Gerrit A. Meijer


European Journal of Gastroenterology & Hepatology | 2009

Diagnostic yield of colorectal neoplasia in daily clinical practice: consequences for future colorectal cancer screening?

J. S. Terhaar sive Droste; Mike E. Craanen; R. W. M. Van Der Hulst; Joep F. W. M. Bartelsman; P.D. Bezemer; K.R. Cappendijk; G. A. Meijer; Linde M. Morsink; Pleun Snel; Hans Tuynman; R.L.J. van Wanrooy; I.C.E. Wesdorp; C. J. J. Mulder


Gastroenterology | 2010

S1978 Delay in Diagnosing Colorectal Cancer in Symptomatic Patients Does Not Affect Tumor Stage and Survival

Jochim S. Terhaar sive Droste; Frank A. Oort; René W. van der Hulst; Veerle M.H. Coupé; Mike E. Craanen; Gerrit A. Meijer; Linde M. Morsink; Otto Visser; Roy van Wanrooy; Chris J. Mulder

Collaboration


Dive into the Mike E. Craanen's collaboration.

Top Co-Authors

Avatar

Gerrit A. Meijer

Netherlands Cancer Institute

View shared research outputs
Top Co-Authors

Avatar

Chris J. Mulder

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Miguel A. Cuesta

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Elisabeth Bloemena

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Bauke Ylstra

VU University Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge